| 1 |
32799638 | Identification of the naphthoquinone derivative inhibitors binding site in heat shock protein 90: an induced-fit docking, molecular dynamics and 3D-QSAR study. | 2021 Oct |
1 |
| 2 |
32868290 | Geldanamycin-Derived HSP90 Inhibitors Are Synthetic Lethal with NRF2. | 2020 Oct 26 |
1 |
| 3 |
25572106 | New, non-quinone fluorogeldanamycin derivatives strongly inhibit Hsp90. | 2015 Jan 19 |
1 |
| 4 |
25668752 | Reaction design, discovery, and development as a foundation to function-oriented synthesis. | 2015 Mar 17 |
1 |
| 5 |
26674599 | HSP90 Inhibitor Geldanamycin as a Radiation Response Modificator in Human Blood Cells. | 2015 Jan-Mar |
1 |
| 6 |
24682466 | 19-substituted benzoquinone ansamycin heat shock protein-90 inhibitors: biological activity and decreased off-target toxicity. | 2014 Jun |
1 |
| 7 |
25117641 | Anti-tumor activity of WK88-1, a novel geldanamycin derivative, in gefitinib-resistant non-small cell lung cancers with Met amplification. | 2014 Oct |
1 |
| 8 |
23710334 | DTNQ-Pro, a Mimetic Dipeptide, Sensitizes Human Colon Cancer Cells to 5-Fluorouracil Treatment. | 2013 |
1 |
| 9 |
23167798 | Biological evaluation of 3-acyl-2-arylamino-1,4-naphthoquinones as inhibitors of Hsp90 chaperoning function. | 2012 |
2 |
| 10 |
21156818 | Role for NAD(P)H:quinone oxidoreductase 1 and manganese-dependent superoxide dismutase in 17-(allylamino)-17-demethoxygeldanamycin-induced heat shock protein 90 inhibition in pancreatic cancer cells. | 2011 Mar |
1 |
| 11 |
19908836 | Dihydroxyphenylisoindoline amides as orally bioavailable inhibitors of the heat shock protein 90 (hsp90) molecular chaperone. | 2010 Jan 14 |
1 |
| 12 |
19308924 | Rational biosynthetic engineering for optimization of geldanamycin analogues. | 2009 May 4 |
1 |
| 13 |
19441108 | Targeting heat shock protein 90 with non-quinone inhibitors: a novel chemotherapeutic approach in human hepatocellular carcinoma. | 2009 Jul |
1 |
| 14 |
19952119 | The antiproliferative activity of the heat shock protein 90 inhibitor IPI-504 is not dependent on NAD(P)H:quinone oxidoreductase 1 activity in vivo. | 2009 Dec |
1 |
| 15 |
18393300 | Stability of the Hsp90 inhibitor 17AAG hydroquinone and prevention of metal-catalyzed oxidation. | 2008 Dec |
1 |
| 16 |
19568319 | Synthesis of a versatile metacyclophane macrolactam. | 2008 Jan 1 |
1 |
| 17 |
17662999 | Mechanistic studies on Hsp90 inhibition by ansamycin derivatives. | 2007 Sep 14 |
1 |
| 18 |
17163756 | Tumor selectivity of Hsp90 inhibitors: the explanation remains elusive. | 2006 Jun 20 |
1 |
| 19 |
15867239 | Phase I pharmacokinetic-pharmacodynamic study of 17-(allylamino)-17-demethoxygeldanamycin (17AAG, NSC 330507), a novel inhibitor of heat shock protein 90, in patients with refractory advanced cancers. | 2005 May 1 |
2 |
| 20 |
15202892 | Biotinylated geldanamycin. | 2004 Jun 25 |
1 |